Epilive, a prescription drug, is manufactured in various forms such as Tablet, Injection, Syrup. Epilepsy are some of its major therapeutic uses. Epilive also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Epilive. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Epilive also has some side effects, the most common being Fatigue, Headache, Drowsiness. While these are the most often observed Epilive side effects, there are can be others also. These have been listed below. These side effects of Epilive are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Epilive's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Epilive has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Epilive related warnings section.
Other contraindications of Epilive have been discussed in the sections ahead.
Drug interactions for Epilive have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Epilive is considered not safe while driving, and is not addictive.
Epilive is used to treat the following -
Based on research, the following side effects have been observed when Epilive is used -
Moderate
Mild
Common
Epilive should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Epilive unless your doctor advises you to do so -
Is this Epilive habit forming or addictive?
Forming a habit of Epilive has not been reported.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420